These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 10740367

  • 1. The fetal and neonatal outcomes of Rhesus D antibody affected pregnancies in Northern Ireland.
    Craig S, Morris K, Tubman T, McClure B.
    Ir Med J; 2000; 93(1):17-8. PubMed ID: 10740367
    [Abstract] [Full Text] [Related]

  • 2. The clinical outcome of non-RhD antibody affected pregnancies in Northern Ireland.
    Chandrasekar A, Morris KG, Tubman TR, Tharma S, McClelland WM.
    Ulster Med J; 2001 Nov; 70(2):89-94. PubMed ID: 11795772
    [Abstract] [Full Text] [Related]

  • 3. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
    Chilcott J, Tappenden P, Lloyd Jones M, Wight J, Forman K, Wray J, Beverley C.
    BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
    [Abstract] [Full Text] [Related]

  • 4. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
    Craig JS, McClure BG, Tubman TR.
    BMJ; 1998 May 23; 316(7144):1611. PubMed ID: 9616034
    [No Abstract] [Full Text] [Related]

  • 5. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies.
    Tiblad E, Westgren M, Pasupathy D, Karlsson A, Wikman AT.
    Acta Obstet Gynecol Scand; 2013 Sep 23; 92(9):1079-85. PubMed ID: 23750781
    [Abstract] [Full Text] [Related]

  • 6. The pregnant Rhesus negative Nigerian woman.
    Kotila TR, Odukogbe AA, Okunlola MA, Olayemi O, Obisesan KA.
    Niger Postgrad Med J; 2005 Dec 23; 12(4):305-7. PubMed ID: 16380744
    [Abstract] [Full Text] [Related]

  • 7. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
    Koelewijn JM, de Haas M, Vrijkotte TG, Bonsel GJ, van der Schoot CE.
    Transfusion; 2008 Aug 23; 48(8):1721-9. PubMed ID: 18507749
    [Abstract] [Full Text] [Related]

  • 8. Routine antenatal anti-D prophylaxis and patient compliance with the two-dose regimen.
    Chaffe B, Ford J, Bills V.
    Transfus Med; 2007 Oct 23; 17(5):399-403. PubMed ID: 17903141
    [Abstract] [Full Text] [Related]

  • 9. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
    Starcević M, Mataija M, Sović D, Dodig J, Matijević R, Kukuruzović M.
    Acta Med Croatica; 2011 Mar 23; 65(1):49-54. PubMed ID: 21568074
    [Abstract] [Full Text] [Related]

  • 10. [Epidemiology of anti-D allo-immunization during pregnancy].
    Branger B, Winer N.
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb 23; 35(1 Suppl):1S87-1S92. PubMed ID: 16495833
    [Abstract] [Full Text] [Related]

  • 11. The role of preimplantation genetic diagnosis in the management of severe rhesus alloimmunization: first unaffected pregnancy: case report.
    Seeho SK, Burton G, Leigh D, Marshall JT, Persson JW, Morris JM.
    Hum Reprod; 2005 Mar 23; 20(3):697-701. PubMed ID: 15661826
    [Abstract] [Full Text] [Related]

  • 12. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
    Katsulov A.
    Akush Ginekol (Sofiia); 1997 Mar 23; 36(2):1-2. PubMed ID: 9471891
    [No Abstract] [Full Text] [Related]

  • 13. Causes and clinical consequences of Rhesus (D) haemolytic disease of the newborn: a study of a Scottish population, 1985-1990.
    Hughes RG, Craig JI, Murphy WG, Greer IA.
    Br J Obstet Gynaecol; 1994 Apr 23; 101(4):297-300. PubMed ID: 8199074
    [Abstract] [Full Text] [Related]

  • 14. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E, Cavelier B, Bonneau JC, Rouger P.
    Transfus Clin Biol; 2005 Feb 23; 12(1):45-55. PubMed ID: 15814293
    [Abstract] [Full Text] [Related]

  • 15. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM.
    Transfusion; 2006 Sep 23; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract] [Full Text] [Related]

  • 16. Haemolytic disease of the newborn: the new NICE guidelines.
    Thompson J.
    J Fam Health Care; 2002 Sep 23; 12(5):133-6. PubMed ID: 12449064
    [Abstract] [Full Text] [Related]

  • 17. A review of maternal alloimmunisation to Rh D in Northern Ireland.
    McCauley CJ, Morris K, Maguire K.
    Transfus Med; 2017 Apr 23; 27(2):132-135. PubMed ID: 28101958
    [Abstract] [Full Text] [Related]

  • 18. The investigation of infants with RhD-negative mothers: can we safely omit the umbilical cord blood direct antiglobulin test?
    James RM, McGuire W, Smith DP.
    Arch Dis Child Fetal Neonatal Ed; 2011 Jul 23; 96(4):F301-4. PubMed ID: 20659940
    [Abstract] [Full Text] [Related]

  • 19. [Rhesus prophylaxis--history and current status].
    Behrens O, Lellé RJ.
    Zentralbl Gynakol; 1997 Jul 23; 119(5):204-10. PubMed ID: 9281253
    [Abstract] [Full Text] [Related]

  • 20. An increased risk for non allo-immunization related intrauterine fetal death in RhD-negative patients.
    Ben-David G, Sheiner E, Levy A, Erez O, Mazor M.
    J Matern Fetal Neonatal Med; 2008 Apr 23; 21(4):255-9. PubMed ID: 18330822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.